Abstract
Recently, in advanced non-small cell lung cancer (NSCLC), standard chemotherapy was flanked by biological agents directed against genomic abnormalities, including EGFR and ALK alterations, that significantly improved patient outcome. Despite these achievements, tumour progression almost always occurs and a reassessment of the tumour genetic profile may contribute to modulating the therapeutic regimen. Resampling may provide tissue for additional tests to detect acquired resistance and/or new genetic alterations, but the currently available information is limited. Histological and genetic reassessments of biopsy or surgical tissue samples from 50 non-squamous NSCLC patients before and after at least one systemic treatment were performed. EGFR, KRAS, BRAF, PIK3CA and HER2 mutations were sequenced, p.T790M was identified with real-time PCR, and ALK and MET genomic alterations by fluorescence in situ hybridization. Overall in baseline biopsies, 37/50 (74 %) tumours had genetic alterations, either single (52 %) or multiple (22 %). Among them, 16 were EGFR mutations and 6 ALK rearrangements. In the second tissue sampling, 54 % of cases had additional genomic changes, including newly acquired alterations (81 %) or losses (18 %). The c...Continue Reading
References
Jul 14, 2006·The New England Journal of Medicine·Maureen F ZakowskiUNKNOWN Memorial Sloan-Kettering Cancer Center Lung Cancer OncoGenome Group
Jul 3, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ryotaro MorinagaKazuhiko Nakagawa
Sep 6, 2007·Cancer Science·Tomoya FukuiYoshihiro Matsuno
Dec 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·James BeanWilliam Pao
Sep 12, 2008·Nature Reviews. Cancer·Jane E Visvader, Geoffrey J Lindeman
Mar 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Federico CappuzzoMarileila Varella-Garcia
Jun 27, 2009·Science·Jeffrey M Rosen, Craig T Jordan
Jul 28, 2009·Clinical Lung Cancer·Kim-Son H NguyenDaniel B Costa
Jan 15, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rafael RosellMiquel Taron
Mar 25, 2011·Science Translational Medicine·Lecia V SequistJeffrey A Engelman
Jan 25, 2012·Nature Reviews. Cancer·Ermanno GherardiGeorge Vande Woude
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T
Feb 11, 2012·Science Translational Medicine·Christine M Lovly, William Pao
Sep 13, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A InoueUNKNOWN North-East Japan Study Group
Mar 19, 2013·BMC Cancer·Luisella RighiMauro Papotti
Apr 2, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yi-Long WuYuri Rukazenkov
Apr 5, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Neal I LindemanMarc Ladanyi
May 10, 2013·Chest·Anthony J AlbergSimon D Spivack
Jun 4, 2013·The New England Journal of Medicine·Alice T ShawPasi A Jänne
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistMartin Schuler
Jul 9, 2013·Cancer Treatment Reviews·J RemonP Lianes
Dec 21, 2013·Critical Reviews in Oncology/hematology·F GelsominoM Tiseo
Apr 22, 2014·Expert Opinion on Pharmacotherapy·Gabriele MinutiFederico Cappuzzo
May 23, 2014·JAMA : the Journal of the American Medical Association·Mark G KrisPaul A Bunn
Jun 13, 2014·PloS One·Baoping GuoQing Ke
Jul 1, 2014·Journal of Clinical Pathology·J S RossP J Stephens
Aug 1, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Dec 11, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hans-Ulrich SchildhausReinhard Buettner
Citations
Jan 18, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Luisella RighiMauro Papotti
May 4, 2016·Expert Review of Molecular Diagnostics·Ravi Salgia
Apr 7, 2017·Thoracic Cancer·Maria C MengoliSilvia Novello
Mar 28, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Simona VatranoAnd Mauro Papotti
Jul 5, 2021·Cancer Epidemiology·Elizabeth HedgemanDeirdre Cronin-Fenton